Danaher (NYSE:DHR – Get Free Report) issued an update on its FY 2026 earnings guidance on Wednesday morning. The company provided earnings per share (EPS) guidance of 8.350-8.550 for the period, compared to the consensus estimate of 8.440. The company issued revenue guidance of -.
Danaher Stock Performance
DHR opened at $183.88 on Thursday. Danaher has a 52-week low of $160.93 and a 52-week high of $242.80. The firm has a market capitalization of $130.14 billion, a PE ratio of 35.57, a PEG ratio of 2.52 and a beta of 0.81. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.52 and a current ratio of 1.87. The business’s 50-day simple moving average is $181.33 and its 200 day simple moving average is $205.28.
Danaher (NYSE:DHR – Get Free Report) last released its earnings results on Monday, April 20th. The conglomerate reported $2.06 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.94 by $0.12. The business had revenue of $5.95 billion for the quarter, compared to analyst estimates of $6 billion. Danaher had a return on equity of 10.91% and a net margin of 14.89%.Danaher’s revenue was up 3.7% on a year-over-year basis. During the same quarter in the prior year, the company posted $1.88 earnings per share. As a group, sell-side analysts expect that Danaher will post 8.43 earnings per share for the current fiscal year.
Danaher Announces Dividend
Analysts Set New Price Targets
A number of brokerages have weighed in on DHR. Wells Fargo & Company lowered their price target on Danaher from $240.00 to $212.00 and set an “equal weight” rating on the stock in a research report on Wednesday, April 22nd. The Goldman Sachs Group lowered their price target on Danaher from $265.00 to $230.00 and set a “buy” rating on the stock in a research report on Monday, April 13th. Wall Street Zen downgraded Danaher from a “buy” rating to a “hold” rating in a research report on Saturday, April 25th. Weiss Ratings reissued a “hold (c)” rating on shares of Danaher in a research report on Friday, March 27th. Finally, TD Cowen lowered their price target on Danaher from $245.00 to $240.00 and set a “buy” rating on the stock in a research report on Wednesday, April 22nd. One investment analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating and five have assigned a Hold rating to the stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $235.14.
Check Out Our Latest Report on DHR
Hedge Funds Weigh In On Danaher
Several institutional investors and hedge funds have recently made changes to their positions in the company. GW&K Investment Management LLC grew its position in shares of Danaher by 8.4% in the fourth quarter. GW&K Investment Management LLC now owns 605 shares of the conglomerate’s stock valued at $138,000 after purchasing an additional 47 shares during the last quarter. Kestra Private Wealth Services LLC grew its position in shares of Danaher by 0.3% in the third quarter. Kestra Private Wealth Services LLC now owns 15,421 shares of the conglomerate’s stock valued at $3,057,000 after purchasing an additional 48 shares during the last quarter. Snowden Capital Advisors LLC grew its position in shares of Danaher by 0.6% in the second quarter. Snowden Capital Advisors LLC now owns 9,919 shares of the conglomerate’s stock valued at $1,963,000 after purchasing an additional 55 shares during the last quarter. Cloud Capital Management LLC grew its position in shares of Danaher by 2.8% in the fourth quarter. Cloud Capital Management LLC now owns 2,112 shares of the conglomerate’s stock valued at $484,000 after purchasing an additional 57 shares during the last quarter. Finally, CYBER HORNET ETFs LLC grew its position in shares of Danaher by 3.6% in the third quarter. CYBER HORNET ETFs LLC now owns 1,750 shares of the conglomerate’s stock valued at $347,000 after purchasing an additional 61 shares during the last quarter. Institutional investors and hedge funds own 79.05% of the company’s stock.
Danaher Company Profile
Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.
Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.
See Also
- Five stocks we like better than Danaher
- The “Duck Stock” Keeps Quietly Making Money for Shareholders
- As Shares Fall, Analyst Are Boosting their Broadcom Price Targets
- Everpure: AI Storage Uncertainty Overshadows Breakneck Growth
- This Tech ETF Is Beating QQQ—and Canada May Be Part of the Reason
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.
